170 related articles for article (PubMed ID: 17492768)
1. PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells.
Loberg RD; Tantivejkul K; Craig M; Neeley CK; Pienta KJ
J Cell Biochem; 2007 Aug; 101(5):1292-300. PubMed ID: 17492768
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration.
Popovic M; Laumonnier Y; Burysek L; Syrovets T; Simmet T
J Leukoc Biol; 2008 Jul; 84(1):215-23. PubMed ID: 18436581
[TBL] [Abstract][Full Text] [Related]
5. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells.
Yufu T; Hirano K; Bi D; Hirano M; Nishimura J; Iwamoto Y; Kanaide H
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1506-11. PubMed ID: 15860737
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
7. PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism.
Tantivejkul K; Loberg RD; Mawocha SC; Day LL; John LS; Pienta BA; Rubin MA; Pienta KJ
J Cell Biochem; 2005 Oct; 96(3):641-52. PubMed ID: 16052512
[TBL] [Abstract][Full Text] [Related]
8. Cdc42 and RhoA are differentially regulated during arachidonate-mediated HeLa cell adhesion.
Roberts LA; Glenn H; Hahn CS; Jacobson BS
J Cell Physiol; 2003 Jul; 196(1):196-205. PubMed ID: 12767056
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitors alter adhesivity of prostatic cancer cells to extracellular matrix components.
Skogseth H; Holt RU; Larsson E; Halgunset J
APMIS; 2006 Mar; 114(3):225-33. PubMed ID: 16643189
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Riewald M; Petrovan RJ; Donner A; Ruf W
J Endotoxin Res; 2003; 9(5):317-21. PubMed ID: 14577849
[TBL] [Abstract][Full Text] [Related]
12. Activation of endothelial cell protease activated receptor 1 by the protein C pathway.
Riewald M; Petrovan RJ; Donner A; Mueller BM; Ruf W
Science; 2002 Jun; 296(5574):1880-2. PubMed ID: 12052963
[TBL] [Abstract][Full Text] [Related]
13. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac.
van Golen KL; Ying C; Sequeira L; Dubyk CW; Reisenberger T; Chinnaiyan AM; Pienta KJ; Loberg RD
J Cell Biochem; 2008 Aug; 104(5):1587-97. PubMed ID: 18646053
[TBL] [Abstract][Full Text] [Related]
14. The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion.
Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
Int J Oncol; 2013 Feb; 42(2):565-73. PubMed ID: 23242308
[TBL] [Abstract][Full Text] [Related]
15. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
Kamath L; Meydani A; Foss F; Kuliopulos A
Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
[TBL] [Abstract][Full Text] [Related]
16. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
17. RhoB affects macrophage adhesion, integrin expression and migration.
Wheeler AP; Ridley AJ
Exp Cell Res; 2007 Oct; 313(16):3505-16. PubMed ID: 17692842
[TBL] [Abstract][Full Text] [Related]
18. Stromal factors involved in prostate carcinoma metastasis to bone.
Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
[TBL] [Abstract][Full Text] [Related]
19. Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration.
Hatziapostolou M; Polytarchou C; Panutsopulos D; Covic L; Tsichlis PN
Cancer Res; 2008 Mar; 68(6):1851-61. PubMed ID: 18339866
[TBL] [Abstract][Full Text] [Related]
20. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
